A Study of the Safety, Tolerability, and Pharmacokinetics of NYR-BI03 in Healthy Participants

计划入组 48 人 · 首次发布于 2025 年 3 月 25 日

A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

计划入组 60 人 · 首次发布于 2020 年 10 月 28 日

Influence of Cardiopulmonary Bypass, and Sevoflurane or Propofol Anesthesia, on Tissue Oxygen Saturation.

计划入组 64 人 · 首次发布于 2015 年 11 月 1 日

bn03

BT03

B03

MYR GmbH

Germany

NYU LANGONE HEALTH

United States

NYC SURGICAL ASSOCIATES

United States

Nyrada's NYR-BI03 Shows Promise in Traumatic Brain Injury and Begins Phase 1 Clinical Trial

Nyrada's NYR-BI03 Advances to Phase I Trials After Promising Preclinical Safety Results

Roche to Acquire Poseida Therapeutics; Merck, AstraZeneca, and Novartis Report Pipeline Success